Allogeneic placenta derived mesenchymal stem cell therapy (Medicrinia)

N/A

Report date: 2024/08/06 11:09:31

Base Information

Drug NameAllogeneic placenta derived mesenchymal stem cell therapy (Medicrinia)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Source of cells > Placenta-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Donor > Allogeneic
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedicrinia Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMedicrinia Co Ltd
Inactive CompaniesN/A
Active IndicationsOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A